← Eichor
Condition: Metastatic Malignant Neoplasm In The Peritoneum Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Metastatic Malignant Neoplasm In The Peritoneum

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Phase 2 · 1 location(s) · Michael Bau Mortensen · NCT03280511
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence
Phase N/A · 1 location(s) · Fudan University · NCT06903325
INTERACT Stomach-II
Phase 2 · 3 location(s) · Erasmus Medical Center · NCT07133490
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373
Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06929013
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07001592
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Periton
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06597526
The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies
Phase 2 · 1 location(s) · The University of Hong Kong · NCT06367270
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · 483 location(s) · National Cancer Institute (NCI) · NCT05564377
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
Phase 3 · 5 location(s) · Uppsala University · NCT04861558
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of P
Phase 2 · 1 location(s) · Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. · NCT07107633
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Phase N/A · 13 location(s) · Chinese Academy of Sciences · NCT05722275
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Phase 2 · 1 location(s) · Mayo Clinic · NCT04858009
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Periton
Phase 2 · 1 location(s) · Mayo Clinic · NCT05753306
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Ca
Phase 1 · 2 location(s) · Arjun Mittra · NCT06269978
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Phase N/A · 2 location(s) · Region Skane · NCT05755672
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherap
NA · 1 location(s) · Yale University · NCT07291180
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07247396
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ov
Phase 1 · 6 location(s) · Hospices Civils de Lyon · NCT04811703
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal
Phase 3 · 7 location(s) · Magnus Nilsson · NCT07304271
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07411599
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05742425
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT06016179
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
Phase N/A · 1 location(s) · The Christie NHS Foundation Trust · NCT05513716
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advance
Phase 2 · 1 location(s) · University of Chicago · NCT04107077
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Phase 4 · 31 location(s) · Hospital Universitario de Fuenlabrada · NCT05250648
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gast
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT04329494
Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06675136
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatm
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06519591
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.